HARVARD BIOSCIENCE, INC. Future Amortization Expense, Year Five (Deprecated 2012-01-31)
HARVARD BIOSCIENCE, INC. (HBIO) reported Future Amortization Expense, Year Five (Deprecated 2012-01-31) of $1.80 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearFive · last filed 2013-03-18
- HARVARD BIOSCIENCE, INC. future amortization expense, year five (deprecated 2012-01-31) for the quarter ending 2012-12-31 was -$300.00K.
- HARVARD BIOSCIENCE, INC. future amortization expense, year five (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $100.00K.
- HARVARD BIOSCIENCE, INC. future amortization expense, year five (deprecated 2012-01-31) for fiscal 2012 was $1.80M.
| Period end | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 9 month | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$200.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.80M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.10M 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $2.00M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |